IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novo Holdings A/S

Q3 2014 Holdings

Filed 2014-11-14 | 13 holdings | $34.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Akebia Therapeutics Inc(AKBA)COM00972D105$33.6M1,516,38797.1%
Vanguard Index FDS(VTI)TOTAL STK MKT922908769$301.6K2,979,1000.9%
Ophthotech CorpCOM683745103$268.5K6,896,8190.8%
Vanguard Intl Equity Index F(VGK)FTSE EUROPE ETF922042874$116.0K2,101,0000.3%
Inogen Inc(INGN)COM45780L104$111.7K5,419,4490.3%
Otonomy IncCOM68906L105$52.2K2,175,0250.2%
Alder Biopharmaceuticals Inc(ALDR1EUR)COM014339105$40.6K3,201,1830.1%
Flexion Therapeutics IncCOM33938J106$32.6K1,783,1310.1%
ZS Pharma IncCOM98979G105$19.9K506,7300.1%
Tetraphase Pharmaceuticals IncCOM88165N105$18.0K900,0000.1%
Tokai Pharmaceuticals IncCOM88907J107$15.5K1,075,0370.0%
Wright MED Group IncRIGHT 03/01/201998235T115$10.1K$4,720,0650.0%
Intersect ENT IncCOM46071F103$5.4K350,0000.0%